Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2259525
                    [Title] => Drugmaker Merck acquires Prometheus for nearly $11 bn
                    [Summary] => The company is developing a treatment for autoimmune diseases, including ulcerative colitis and Crohn's disease, dubbed PRA023.
                    [DatePublished] => 2023-04-17 07:51:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => https://media.philstar.com/photos/2021/11/18/molnupiravir_2021-11-18_11-02-36414_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2140538
                    [Title] => Merck expects COVID-19 pill to reach rich and poor countries simultaneously
                    [Summary] => US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus pill is made available in wealthy and poor countries at almost the same time. 
                    [DatePublished] => 2021-11-11 07:59:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/11/11/merck-molnupiravir_2021-11-11_07-59-13_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 2133582
                    [Title] => Merck seeks US authorization for COVID-19 treatment pill
                    [Summary] => Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalizations by 50 percent.
                    [DatePublished] => 2021-10-12 08:35:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1807254
                    [AuthorName] => Sarah Titterton
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => https://media.philstar.com/photos/2021/10/12/merck-pills_2021-10-12_08-36-00_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 1365709
                    [Title] => FDA OKs Merck drug, 1st in new cancer drug class
                    [Summary] => 
U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.

                    [DatePublished] => 2014-09-05 05:14:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 1347599
                    [Title] => Studies see new risks for cholesterol drug niacin
                    [Summary] => 
New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use.

                    [DatePublished] => 2014-07-18 02:08:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 1308007
                    [Title] => Many Pinoys suffering from neuropathy
                    [Summary] => 
Despite its debilitating effects on a person’s life, neuropathy remains an unrecognized and underestimated condition hounding many Filipinos now, according to experts.

                    [DatePublished] => 2014-04-03 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 926523
                    [Title] => 1 in 10 Filipinos suffer infertility - study
                    [Summary] => 
One in 10 Filipinos is suffering one or more conditions that prevent them from conceiving, showed results of a study commissioned by pharmaceutical firm Merck Serono.

                    [DatePublished] => 2013-04-03 17:06:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1761201
                    [AuthorName] => Tam Noda
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 919989
                    [Title] => FDA probes new pancreas risks with diabetes drugs
                    [Summary] => 
The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

                    [DatePublished] => 2013-03-15 01:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 841594
                    [Title] => Bristol-Myers ends hepatitis C drug development
                    [Summary] => 
Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

 
                    [DatePublished] => 2012-08-24 08:24:23
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 838600
                    [Title] => Merck Serono marks Neurobion's 50th year
                    [Summary] => 
Merck Serono, a division of Merck in Darmstadt, Germany, recently celebrated the 50th anniversary of Neurobion, one of the first vitamin combinations in the world.
                    [DatePublished] => 2012-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

merck

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2259525
                    [Title] => Drugmaker Merck acquires Prometheus for nearly $11 bn
                    [Summary] => The company is developing a treatment for autoimmune diseases, including ulcerative colitis and Crohn's disease, dubbed PRA023.
                    [DatePublished] => 2023-04-17 07:51:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => https://media.philstar.com/photos/2021/11/18/molnupiravir_2021-11-18_11-02-36414_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 2140538
                    [Title] => Merck expects COVID-19 pill to reach rich and poor countries simultaneously
                    [Summary] => US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus pill is made available in wealthy and poor countries at almost the same time. 
                    [DatePublished] => 2021-11-11 07:59:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => https://media.philstar.com/photos/2021/11/11/merck-molnupiravir_2021-11-11_07-59-13_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 2133582
                    [Title] => Merck seeks US authorization for COVID-19 treatment pill
                    [Summary] => Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalizations by 50 percent.
                    [DatePublished] => 2021-10-12 08:35:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1807254
                    [AuthorName] => Sarah Titterton
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => https://media.philstar.com/photos/2021/10/12/merck-pills_2021-10-12_08-36-00_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 1365709
                    [Title] => FDA OKs Merck drug, 1st in new cancer drug class
                    [Summary] => 
U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.

                    [DatePublished] => 2014-09-05 05:14:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 1347599
                    [Title] => Studies see new risks for cholesterol drug niacin
                    [Summary] => 
New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use.

                    [DatePublished] => 2014-07-18 02:08:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 1308007
                    [Title] => Many Pinoys suffering from neuropathy
                    [Summary] => 
Despite its debilitating effects on a person’s life, neuropathy remains an unrecognized and underestimated condition hounding many Filipinos now, according to experts.

                    [DatePublished] => 2014-04-03 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 926523
                    [Title] => 1 in 10 Filipinos suffer infertility - study
                    [Summary] => 
One in 10 Filipinos is suffering one or more conditions that prevent them from conceiving, showed results of a study commissioned by pharmaceutical firm Merck Serono.

                    [DatePublished] => 2013-04-03 17:06:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1761201
                    [AuthorName] => Tam Noda
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 919989
                    [Title] => FDA probes new pancreas risks with diabetes drugs
                    [Summary] => 
The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

                    [DatePublished] => 2013-03-15 01:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

            [8] => Array
                (
                    [ArticleID] => 841594
                    [Title] => Bristol-Myers ends hepatitis C drug development
                    [Summary] => 
Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

 
                    [DatePublished] => 2012-08-24 08:24:23
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [9] => Array
                (
                    [ArticleID] => 838600
                    [Title] => Merck Serono marks Neurobion's 50th year
                    [Summary] => 
Merck Serono, a division of Merck in Darmstadt, Germany, recently celebrated the 50th anniversary of Neurobion, one of the first vitamin combinations in the world.
                    [DatePublished] => 2012-08-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Drugmaker Merck acquires Prometheus for nearly $11 bn

April 17, 2023 - 7:51am

The company is developing a treatment for autoimmune diseases, including ulcerative colitis and Crohn's disease, dubbed ...

Business

Merck expects COVID-19 pill to reach rich and poor countries simultaneously

November 11, 2021 - 7:59am

US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus...

Health And Family

Merck seeks US authorization for COVID-19 treatment pill

By Sarah Titterton | October 12, 2021 - 8:35am

Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalizations...

World

FDA OKs Merck drug, 1st in new cancer drug class

September 5, 2014 - 5:14am

U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.

Health And Family

Studies see new risks for cholesterol drug niacin

July 18, 2014 - 2:08am

New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems...

Health And Family

Many Pinoys suffering from neuropathy

April 3, 2014 - 12:00am

Despite its debilitating effects on a person’s life, neuropathy remains an unrecognized and underestimated condition hounding many Filipinos now, according to experts.

Science and Environment

1 in 10 Filipinos suffer infertility - study

By Tam Noda | April 3, 2013 - 5:06pm

One in 10 Filipinos is suffering one or more conditions that prevent them from conceiving, showed results of a study commissioned by pharmaceutical firm Merck Serono.

Health And Family

FDA probes new pancreas risks with diabetes drugs

March 15, 2013 - 1:00am

The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.

World

Bristol-Myers ends hepatitis C drug development

August 24, 2012 - 8:24am

Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.  

Merck Serono marks Neurobion's 50th year

August 16, 2012 - 12:00am

Merck Serono, a division of Merck in Darmstadt, Germany, recently celebrated the 50th anniversary of Neurobion, one of the first vitamin combinations in the world.

Science and Environment